Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel

BACKGROUND: Platelet P2Y12 antagonist ticagrelor reduces mortality after acute myocardial infarction (AMI) compared to clopidogrel, but the underlying mechanism is unknown. Because activated platelets, leukocytes, and endothelial cells release proinflammatory and prothrombotic extracellular vesicles...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Thromb Haemost
Glavni autori: Gasecka, Aleksandra, Nieuwland, Rienk, Budnik, Monika, Dignat‐George, Françoise, Eyileten, Ceren, Harrison, Paul, Lacroix, Romaric, Leroyer, Aurélie, Opolski, Grzegorz, Pluta, Kinga, van der Pol, Edwin, Postuła, Marek, Siljander, Pia, Siller‐Matula, Jolanta M., Filipiak, Krzysztof J.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
THROMBOSIS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065161/
https://ncbi.nlm.nih.gov/pubmed/31833175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14689
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items